4//SEC Filing
Patel Naimish 4
Accession 0001193125-25-230508
CIK 0001674416other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:37 PM ET
Size
5.4 KB
Accession
0001193125-25-230508
Insider Transaction Report
Form 4
Patel Naimish
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-03+16,500→ 16,500 totalExercise: $67.74Exp: 2035-10-03→ Common Shares (16,500 underlying)
Footnotes (1)
- [F1]This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0002021679
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:37 PM ET
- Size
- 5.4 KB